6 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Potential Treatment ... Agents for Treatment ... infection Episode #Pharmacology ... IDSA2017 #Adjunct #Antibiotics
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Epidemiology: • #1 ... non-toxigenic • Stool PCR ... 10 mg/kg IV x 1 ... ciab549 #CDI #Cdiff ... #infectiousdiseases
ANTIBIOTICS WITH ANAEROBE COVERAGE - Antibiotics Class Overview
 1. Metronidazole (Flagyl)(PO and IV)
 2. Clindamycin –
ANTIBIOTICS WITH ... Class Overview 1. ... Combined PCN/Beta-Lactamase ... Metronidazole (unless for C.diff ... #Pharmacology #Antibiotics
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... Pneumocystis #Pneumonia #IDSA ... #Prevention #Treatment ... HIVAIDS #management #pharmacology
CSF Penetration of Antimicrobials

Despite the poor CSF penetration, beta-lactams have the most research documenting successful treatment
documenting successful treatment ... compared to other antibiotic ... classes. 1 only ... Antimicrobials #InfectiousDiseases ... #Pharmacology
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Anti-Pseudomonal - Antibiotics ... develop resistance. 1. ... so use only if PCN-allergic ... empiric Pseudomonas treatment ... Polymyxin B(IV) #Pharmacology